Can Eliquis Prevent Stroke? Understanding Apixaban for Atrial Fibrillation
If you have atrial fibrillation, you may wonder if Eliquis can prevent stroke. The simple answer is yes. Eliquis (apixaban) is a prescription blood thinner specifically designed to reduce stroke risk in people with a heart rhythm disorder called nonvalvular atrial fibrillation.
Shop Medications
,Atrial fibrillation causes your heart to beat irregularly. This irregular rhythm can allow blood to pool in your heart chambers, forming clots. If a clot breaks free and travels to your brain, it can cause a stroke. Eliquis works by making your blood less likely to form these dangerous clots.
In This Article
- How Eliquis Prevents Stroke in Atrial Fibrillation
- Clinical Evidence Supporting Eliquis for Stroke Prevention
- Who Should Consider Eliquis for Stroke Prevention
- Important Limitations and Considerations
- Common Side Effects of Eliquis
- Serious but Rare Side Effects
- Monitoring and Safety While Taking Eliquis
- Cost Considerations and Access
- Making the Decision About Eliquis
- References
How Eliquis Prevents Stroke in Atrial Fibrillation
Eliquis belongs to a class of medications called direct oral anticoagulants (DOACs). These drugs work differently from older blood thinners like warfarin. Eliquis specifically blocks a protein in your blood called factor Xa, which plays a key role in blood clot formation.
When you have atrial fibrillation, your heart’s upper chambers flutter instead of beating normally. This creates areas where blood can sit still and clump together. By preventing clot formation, Eliquis significantly reduces your risk of stroke.
The medication is taken twice daily as an oral tablet. Most people start with a dose of 5 mg twice daily, though your doctor may prescribe a lower 2.5 mg dose based on your age, weight, and kidney function.
Clinical Evidence Supporting Eliquis for Stroke Prevention
The evidence showing that Eliquis can prevent stroke comes from large clinical trials involving thousands of patients. The most important study was called ARISTOTLE, which compared Eliquis directly to warfarin in people with atrial fibrillation.
In this landmark trial, Eliquis was superior to warfarin for preventing stroke and systemic embolism. Patients taking Eliquis had a stroke rate of 1.27% per year compared to 1.60% per year for those taking warfarin. This represents a 21% reduction in stroke risk.
Equally important, Eliquis caused significantly less major bleeding than warfarin while providing superior stroke protection. This combination of better effectiveness and improved safety makes Eliquis a preferred choice for many doctors and patients.
Another study called AVERROES compared Eliquis to aspirin in atrial fibrillation patients who couldn’t take warfarin. Eliquis was clearly superior to aspirin for stroke prevention, further confirming its effectiveness.
Who Should Consider Eliquis for Stroke Prevention
Eliquis is specifically approved for people with nonvalvular atrial fibrillation. Nonvalvular means your atrial fibrillation isn’t caused by a mechanical heart valve or significant mitral valve disease.
Your doctor will assess your stroke risk using clinical scoring systems. These consider factors like your age, whether you’ve had a previous stroke, and whether you have heart failure, high blood pressure, or diabetes. Generally, if you have a moderate to high risk of stroke, anticoagulation with Eliquis may be recommended.
Not everyone with atrial fibrillation needs blood thinners. People with very low stroke risk might be managed with other approaches. Your healthcare provider will weigh your individual stroke risk against your bleeding risk to determine if Eliquis is right for you.
Important Limitations and Considerations
While Eliquis effectively prevents stroke in atrial fibrillation, it’s important to understand its limitations. Recent research shows that Eliquis doesn’t prevent all types of strokes equally well.
A major study published in JAMA looked at using Eliquis to prevent stroke recurrence in patients who had cryptogenic strokes (strokes of unknown cause) with a condition called atrial cardiopathy. This trial found no significant reduction in recurrent stroke with Eliquis compared to aspirin, highlighting that Eliquis isn’t beneficial for all stroke types.
This research reinforces that Eliquis is most effective for preventing strokes specifically related to atrial fibrillation, not strokes from other causes like blocked arteries in the brain or bleeding.
Common Side Effects of Eliquis
Like all blood thinners, Eliquis increases your risk of bleeding. The most common side effects include:
- Easy bruising: You may notice bruises from minor bumps or injuries.
- Minor bleeding: This can include nosebleeds or bleeding gums when brushing teeth.
- Heavy menstrual periods: Women may experience heavier or longer periods.
- Small cuts that bleed longer: Normal cuts may take longer to stop bleeding.
Serious but Rare Side Effects
Serious bleeding events are uncommon but require immediate medical attention:
- Major bleeding episodes: This includes gastrointestinal bleeding or bleeding in the brain.
- Spinal bleeding: Rare but serious risk if you have spinal procedures while taking Eliquis.
- Severe allergic reactions: Very rare but can include difficulty breathing or swelling of the face and throat.
Contact your doctor immediately if you experience unusual bleeding, black or bloody stools, coughing up blood, or severe headaches.
Monitoring and Safety While Taking Eliquis
Unlike warfarin, Eliquis doesn’t require regular blood tests to monitor its effects. However, your doctor will still want to see you periodically to ensure the medication is working well and you’re not experiencing problems.
Before starting Eliquis, tell your doctor about all medications and supplements you take. Some drugs can increase your bleeding risk when combined with Eliquis, including certain pain medications, other blood thinners, and some antibiotics.
Avoid activities that significantly increase your injury risk while taking Eliquis. However, you don’t need to avoid normal daily activities. Many people continue exercising, traveling, and maintaining active lifestyles while taking this medication.
Cost Considerations and Access
Eliquis can be expensive, especially without insurance coverage. The medication typically costs several hundred dollars per month at retail prices. Many insurance plans cover Eliquis, but you may still have significant copays.
If cost is a concern, discuss options with your healthcare provider. Some patients may be candidates for patient assistance programs offered by the manufacturer. Additionally, you can explore safe, reliable cash-pay options through Universal Drugstore, which may offer more affordable access to brand-name and generic Eliquis.
Making the Decision About Eliquis
Deciding whether Eliquis is right for your stroke prevention needs involves careful consideration of your individual circumstances. Your doctor will evaluate your stroke risk, bleeding risk, other health conditions, and personal preferences.
For many people with atrial fibrillation, the benefits of stroke prevention with Eliquis outweigh the bleeding risks. The peace of mind that comes from significantly reducing stroke risk can be life-changing.
However, this decision should always be made in partnership with your healthcare provider. They can help you understand how your specific health profile affects the risks and benefits of taking Eliquis for stroke prevention.
If you have atrial fibrillation and haven’t discussed stroke prevention strategies with your doctor, consider scheduling an appointment. Early prevention is often more effective than treating complications after they occur.
References
- Kamel H, Longstreth WT, Tirschwell DL, et al. Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial. JAMA. 2024;331(7):573–581. Accessed June 15, 2026.
- Seeger J, Wöhrle J. Apixaban: An Update of the Evidence for Its Place in the Prevention of Stroke in Patients with Atrial Fibrillation. Core Evid. 2020 Jan 21;15:1-6. Accessed June 15, 2026.
- Eliquis (apixaban) tablets, for oral use [package insert]. Bristol Myers Squibb. Last updated 4/2025. Accessed June 15, 2026.
- Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE). American College of Cardiology. 2013. Accessed June 15, 2026.